Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Perricone

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Clinical and Experimental Rheumatology|October 19, 2021
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre studyLuca Navarini, Damiano Currado, Francesco Caso, et al.
Clinical and Experimental Rheumatology|August 4, 2019
Transitional care of young people with juvenile idiopathic arthritis in Italy: results of a Delphi consensus surveyAngelo Ravelli, Luigi Sinigaglia, Rolando Cimaz, et al.
Scientific Reports|May 7, 2022
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritisLuca Navarini, Damiano Currado, Annalisa Marino, et al.
Orphanet Journal of Rare Diseases|March 12, 2015
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in ItalyAndrea Zanichelli, Francesco Arcoleo, Maria Pina Barca, et al.
Clinical and Experimental Rheumatology|December 18, 2020
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre studyGiacomo Maria Guidelli, Ombretta Viapiana, Nicoletta Luciano, et al.
BMC Health Services Research|December 16, 2022
A real-world economic analysis of biologic therapies for psoriatic arthritis in Italy: results of the CHRONOS observational longitudinal studyEmanuela Zagni, Micol Frassi, Giuseppa Pagano Mariano, et al.
BMC Rheumatology|September 11, 2022
Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: an ObservatioNal lOngitudinal Study of real-life clinical practice) observational longitudinal studyDelia Colombo, Micol Frassi, Giusy Pagano Mariano, et al.
Women'S Health Reports (New Rochelle, N.Y.)|March 9, 2022
The CHRONOS Real-World Evidence of Biologic Treatments in Psoriatic Arthritis in Italy: A <i>Post Hoc</i> Gender AnalysisDelia Colombo, Micol Frassi, Giuseppa Pagano Mariano, et al.
Frontiers in Immunology|October 4, 2018
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsALoredana Frasca, Raffaella Palazzo, Maria S Chimenti, et al.
Lupus|April 22, 2021
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for RheumatologyGian Domenico Sebastiani, Francesca Romana Spinelli, Elena Bartoloni, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Clinical and Experimental Rheumatology|October 19, 2021
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre studyLuca Navarini, Damiano Currado, Francesco Caso, et al.
Clinical and Experimental Rheumatology|August 4, 2019
Transitional care of young people with juvenile idiopathic arthritis in Italy: results of a Delphi consensus surveyAngelo Ravelli, Luigi Sinigaglia, Rolando Cimaz, et al.
Scientific Reports|May 7, 2022
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritisLuca Navarini, Damiano Currado, Annalisa Marino, et al.
Orphanet Journal of Rare Diseases|March 12, 2015
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in ItalyAndrea Zanichelli, Francesco Arcoleo, Maria Pina Barca, et al.
Clinical and Experimental Rheumatology|December 18, 2020
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre studyGiacomo Maria Guidelli, Ombretta Viapiana, Nicoletta Luciano, et al.
BMC Health Services Research|December 16, 2022
A real-world economic analysis of biologic therapies for psoriatic arthritis in Italy: results of the CHRONOS observational longitudinal studyEmanuela Zagni, Micol Frassi, Giuseppa Pagano Mariano, et al.
BMC Rheumatology|September 11, 2022
Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: an ObservatioNal lOngitudinal Study of real-life clinical practice) observational longitudinal studyDelia Colombo, Micol Frassi, Giusy Pagano Mariano, et al.
Women'S Health Reports (New Rochelle, N.Y.)|March 9, 2022
The CHRONOS Real-World Evidence of Biologic Treatments in Psoriatic Arthritis in Italy: A <i>Post Hoc</i> Gender AnalysisDelia Colombo, Micol Frassi, Giuseppa Pagano Mariano, et al.
Frontiers in Immunology|October 4, 2018
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsALoredana Frasca, Raffaella Palazzo, Maria S Chimenti, et al.
Lupus|April 22, 2021
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for RheumatologyGian Domenico Sebastiani, Francesca Romana Spinelli, Elena Bartoloni, et al.
Pageof 14